Evidence map›Paper›PMID 26513501›Full record

ArticleInvestigative ophthalmology & visual science2015

In Vivo Visualization of Endoplasmic Reticulum Stress in the Retina Using the ERAI Reporter Mouse.

Marcel V Alavi, Wei-Chieh Chiang, Heike Kroeger, Douglas Yasumura, Michael T Matthes, Takao Iwawaki, Matthew M LaVail, Douglas B Gould, Jonathan H Lin

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. The RBPMSiScience · 2023
    Article
  6. Article
  7. Lysine Ubiquitylation Drives Rhodopsin Protein Turnover.Advances in experimental medicine and biology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Achromatopsia mutations target sequential steps of ATF6 activation.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marcel V AlaviDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California, United States.
Wei-Chieh ChiangDepartment of Pathology, University of California, San Diego, La Jolla, California, United States.
Heike KroegerDepartment of Pathology, University of California, San Diego, La Jolla, California, United States.
Douglas YasumuraDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California, United States.
Michael T MatthesDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California, United States.
Takao IwawakiAdvanced Scientific Research Leaders Development Unit, Gunma University, Gunma, Japan.
Matthew M LaVailDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California, United States.
Douglas B GouldDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California, United States 4Department of Anatomy and Institute for Human Genetics, University of California, San Francisco, San Francisco, California, United States.
Jonathan H LinDepartment of Pathology, University of California, San Diego, La Jolla, California, United States 5VA San Diego Healthcare System, San Diego, California, United States.

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Derek Stuart Welsbie · 2012 to 2026
$10.3M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
CELLULAR MECHANISMS OF INHERITED RETINAL DEGENERATIONR01EY001919 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1985 to 2014
$8.3M
RODENT MODELS OF RETINAL DEGENERATIONR01EY006842 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1992 to 2014
$3.6M
Protein Homeostasis and Proteotoxicity MechanismsR01NS088485 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIN, JONATHAN · 2015 to 2024
$3.0M
Endoplasmic Reticulum Stress in Retinal DegenerationR01EY020846 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIN, JONATHAN · 2010 to 2014
$1.9M
Genetically testing interactions of ER and oxidative stresses in retinal diseaseR01EY019514 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOULD, DOUGLAS · 2009 to 2013
$1.9M
BREEDING COLONY WITH INHERITED RETINAL DYSTROPHYU01EY006842 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1986 to 1992
–
Cellular and Molecular Mechanisms of Age-Related Retinal DegenerationI01BX002284 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI LIN, JONATHAN · 2014 to 2023
–
CELLULAR MECHANISMS OF INHERITED RETINAL DEGENERATIONR37EY001919 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1989 to 1998
–
NEUROPHYSIOLOGY OF INTERMEDIATE LEVEL VISIONF32EY006842 · NEI · ROCKEFELLER UNIVERSITY · PI BAKIN, JONATHAN S · 1997 to 1999
–
BLRD VA I01 BX002284NEI NIH HHS EY001919NEI NIH HHS EY006842NEI NIH HHS EY019514NEI NIH HHS EY020846NEI NIH HHS F32 EY006842NEI NIH HHS P30 EY002162NEI NIH HHS P30EY002162NEI NIH HHS P30 EY022589NEI NIH HHS P30EY022589NEI NIH HHS R01 EY001919NEI NIH HHS R01 EY006842NEI NIH HHS R01 EY019514NEI NIH HHS R01 EY020846NINDS NIH HHS NS088485NINDS NIH HHS P30 NS047101NINDS NIH HHS R01 NS088485
6 · The paper itself

Abstract

purposeEndoplasmic reticulum (ER) stress activates inositol requiring enzyme 1 (IRE1), a key regulator of the unfolded protein response. The ER stress activated indicator (ERAI) transgenic mouse expresses a yellow fluorescent GFP variant (Venus) when IRE1 is activated by ER stress. We tested whether ERAI mice would allow for real-time longitudinal studies of ER stress in living mouse eyes.

methodsWe chemically and genetically induced ER stress, and qualitatively and quantitatively studied the Venus signal by fluorescence ophthalmoscopy. We determined retinal cell types that contribute to the signal by immunohistology, and we performed molecular and biochemical assays using whole retinal lysates to assess activity of the IRE1 pathway.

resultsWe found qualitative increase in vivo in fluorescence signal at sites of intravitreal tunicamycin injection in ERAI eyes, and quantitative increase in ERAI mice mated to RhoP23H mice expressing ER stress-inducing misfolded rhodopsin protein. As expected, we found that increased Venus signal arose primarily from photoreceptors in RhoP23H/+;ERAI mice. We found increased Xbp1S and XBP1s transcriptional target mRNA levels in RhoP23H/+;ERAI retinas compared to Rho+/+;ERAI retinas, and that Venus signal increased in ERAI retinas as a function of age.

conclusionsFluorescence ophthalmoscopy of ERAI mice enables in vivo visualization of retinas undergoing ER stress. ER stress activated indicator mice enable identification of individual retinal cells undergoing ER stress by immunohistochemistry. ER stress activated indicator mice show higher Venus signal at older ages, likely arising from amplification of basal retinal ER stress levels by GFP's inherent stability.

Indexed as

AnimalsEndoplasmic ReticulumEndoplasmic Reticulum StressLongitudinal StudiesMembrane ProteinsMiceMice, TransgenicOphthalmoscopyPolymerase Chain ReactionProtein Serine-Threonine KinasesRetinaSignal TransductionTomography, Optical CoherenceTunicamycinUltrasonographyErn2 protein, mouseMembrane ProteinsProtein Serine-Threonine KinasesTunicamycin

Identifiers

PMID26513501
PMCPMC4627472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.